THANK YOU FOR SUBSCRIBING
CureDuchenne LinkTM, which has a broader reach than a registry or biobank, directly connects data and biosamples donated by the Duchenne and Becker muscular dystrophy communities to scientists and people interested in medication research.
FREMONT, CA: BC Platforms (BCP), a global leader in healthcare data management, analytics, and access, and CureDuchenne, a prominent global non-profit organization dedicated to finding and supporting a cure for Duchenne muscular dystrophy, announced a new partnership today. CureDuchenne has integrated BCP's Discovery and Research Platform (DRP) into its newly declared CureDuchenne LinkTM global data platform as part of the agreement.
CureDuchenne LinkTM, which has a broader reach than a registry or biobank, directly connects data and biosamples donated by the Duchenne and Becker muscular dystrophy communities to scientists and people interested in medication research. This data center aids in the discovery of biomarkers as well as the development of future treatments, such as new gene therapies and exon-skipping techniques, by decreasing the need to search for data linked to biosamples. BCP's purpose in this 10-year initiative is to create a data hub capable of completely integrating with a wide range of data sources via its DRP, including aggregate data management and data sharing. BCP will provide storage for data repositories as well as management and analysis tools for genomic, phenotypic, sample, and whole-genome sequencing data.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
More in News